Clinical trial
ECT in Clozapine Refractory Schizophrenia
NCT00042224 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ECT in Clozapine Refractory Schizophrenia
- Lead sponsor
- Northwell Health
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2000
- Completion date
- July 31, 2008
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.